Daito Pharmaceutical Co., Ltd.
Manufactures APIs, generic drugs, and health foods; provides contract manufacturing services.
4577 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 富山市八日町３２６番地
- Website:
- https://www.eng.daitonet.co.jp/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Daito Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. The company operates an integrated business model that covers the entire production process, from active pharmaceutical ingredients (APIs) to finished formulation products, including powders, granules, and tablets. Its portfolio consists of generic drugs (both prescription and over-the-counter), health foods, and quasi-drugs. In addition to its own products, Daito serves other pharmaceutical firms by supplying APIs for generic products and offering contract manufacturing (CMO) services. The company emphasizes a stable supply of high-quality products managed by a strict quality assurance system.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Daito Pharmaceutical Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-27 08:15 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2025-08-27 08:13 |
Annual Report
有価証券報告書－第83期(2024/06/01－2025/05/31)
|
Japanese | 1.4 MB | |
| 2025-06-12 09:16 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.3 KB | |
| 2025-05-13 09:22 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.0 KB | |
| 2025-04-11 08:53 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 25.3 KB | |
| 2025-03-12 08:08 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.7 KB | |
| 2025-02-13 08:56 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.2 KB | |
| 2025-01-17 09:04 |
Regulatory News Service
臨時報告書
|
Japanese | 34.3 KB | |
| 2025-01-10 08:56 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2025-01-10 08:54 |
Interim Report
半期報告書－第83期(2024/06/01－2025/05/31)
|
Japanese | 194.9 KB | |
| 2024-09-02 08:00 |
Regulatory News Service
臨時報告書
|
Japanese | 21.8 KB | |
| 2024-08-30 07:43 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-08-30 07:41 |
Regulatory News Service
内部統制報告書－第82期(2023/06/01－2024/05/31)
|
Japanese | 22.1 KB | |
| 2024-08-30 07:38 |
Annual Report
有価証券報告書－第82期(2023/06/01－2024/05/31)
|
Japanese | 1.3 MB | |
| 2024-08-28 09:43 |
Regulatory News Service
臨時報告書
|
Japanese | 20.4 KB |
Automate Your Workflow. Get a real-time feed of all Daito Pharmaceutical Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Daito Pharmaceutical Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}